Susannah Gray

Susannah Gray

Director/Board Member at THERAVANCE BIOPHARMA, INC.

Net worth: 146 M $ as of 2024-03-30

63 year
Health Technology
Finance
Commercial Services

Profile

Susannah Gray is currently the Director at The German Marshall Fund of United States, Wesleyan University, StreetSquash, Theravance Biopharma, Inc., Maravai Life Sciences, Inc., Biosplice Therapeutics, Inc., 4D Molecular Therapeutics, Inc., Susan G.
Komen Foundation, Morphic Holding, Inc., Biosplice LLC, Colby College Museum of Art, Maravai Lifesciences Holdings, Inc., and Morphic Therapeutic, Inc. She previously worked as the Managing Director at Merrill Lynch & Co., Inc., Director at Susan G.
Komen for the Cure, Independent Director at Apria, Inc., Analyst at CIBC World Markets Corp.
(Old), and Executive Vice President-Finance & Strategy at RP Management LLC and Royalty Pharma Management LLC.
She received her undergraduate degree from Wesleyan University in 1982 and her MBA from Columbia Business School in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
RPI US Partners 2019 LP
2.24%
2020-06-15 4,788,526 ( 2.24% ) 145 M $ 2024-03-30
2023-07-16 60,123 ( 0.05% ) 521 266 $ 2024-03-30
2023-05-01 20,951 ( 0.04% ) 187 930 $ 2024-03-30
2023-05-22 0 ( -.--% ) - $ 2024-03-30
2023-05-31 0 ( -.--% ) - $ 2024-03-30

Susannah Gray active positions

CompaniesPositionStart
4D MOLECULAR THERAPEUTICS, INC. Director/Board Member 2020-06-30
MARAVAI LIFESCIENCES HOLDINGS, INC. Director/Board Member 2020-10-31
MORPHIC HOLDING, INC. Director/Board Member 2021-04-26
THERAVANCE BIOPHARMA, INC. Director/Board Member 2023-02-25
Director/Board Member -
Director/Board Member -
Biosplice LLC Director/Board Member -
Director/Board Member -
Wesleyan University Director/Board Member -
░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Susannah Gray

Former positions of Susannah Gray

CompaniesPositionEnd
░░░░░ ░░ ░░░░░ ░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Susannah Gray's experience

Training of Susannah Gray

Wesleyan University Undergraduate Degree
Columbia Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Susannah Gray's experience

Connections

100 +

1st degree connections

19

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
THERAVANCE BIOPHARMA, INC.

Health Technology

4D MOLECULAR THERAPEUTICS, INC.

Health Technology

MORPHIC HOLDING, INC.

Health Technology

MARAVAI LIFESCIENCES HOLDINGS, INC.

Health Technology

Private companies13

Finance

Finance

Commercial Services

Health Services

Commercial Services

Commercial Services

Finance

Commercial Services

Susan G. Komen Foundation

Health Technology

Health Services

Finance

Biosplice LLC

See company connections